Emerging role of anti-proliferative protein BTG1 and BTG2

키워드

참고문헌 (64)

1. Coleman WB, "Genomic catastrophe and neoplastic transformation", Am J Pathol, 185, pp.1846~1849 (2015)
2. Chen Y, "BTG", Tob family members Tob1 and Tob2 inhibit proliferation of mouse embryonic stem cells via Id3 mRNA degradation, 2015, pp.462, 208~214
3. Yoshida Y, "ANA, a novel member of Tob", BTG1 family, is expressed in the ventricular zone of the developing central nervous system, 1998, pp.16, 2687~2693
4. el-Ghissassi F, "BTG2(TIS21", PC3)induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells, 2002, pp.21, 6772~6778
5. Rouault JP, "BTG1, a member of a new family of antiproliferative genes", EMBO J, 11, pp.1663~1670 (1992)
6. Sasajima H, "Polyubiquitination of the B-cell translocation gene 1 and 2 proteins is promoted by the SCF ubiquitin ligase complex containing betaTrCP", Biol Pharm Bull, 35, pp.1539~1545 (2012)
7. Park TJ, "Skp2enhances polyubiquitination and degradation of TIS21", BTG2, Exp Cell Res, pp.2009, 315[DOI]
8. Fei JF, "3’ UTR-dependent, miR-92-mediated restriction of Tis21 expression maintains asymmetric neural stem cell division to ensure proper neocortex size", Cell Rep, 7, pp.398~411 (2014)
9. Kawakubo H, "Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein", Cancer Res, 66, pp.7075~7082 (2006)
10. Rouault JP, "Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway", Nat Genet, 14, pp.482~486 (1996)
11. Cortes U, "BTG gene expression in the p53-dependent and-independent cellular response to DNA damage", Mol Carcinog, 27, pp.57~64 (2000)
12. Prevot D, "The leukemiaassociated protein Btg1 and the p53-regulated protein Btg2 interact with the homeoprotein Hoxb9 and enhance its transcriptional activation", J Biol Chem, 275, pp.147~153 (2000)
13. Busson M, "Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation", Oncogene, 24, pp.1698~1710 (2005)
14. Hu XD, "BTG2 is an LXXLLdependent co-repressor for androgen receptor transcriptional activity", Biochem Biophys Res Commun, 404, pp.903~909 (2011)
15. Lin WJ, "The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase", J Biol Chem, 271, pp.15034~15044 (1996)
16. Bedford MT, "Protein arginine methylation in mammals : who, what, and why", Mol Cell, 33, pp.1~13 (2009)
17. Passeri D, "Btg2 enhances retinoic acid-induced differentiation by modulating histone H4 methylation and acetylation", Mol Cell Biol, 26, pp.5023~5032 (2006)
18. Hata K, "Role for Btg1and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement", Exp Cell Res, 313, pp.2356~2366 (2007)
19. Cho JW, "Identification of B-cell translocation gene 1 as a biomarker for monitoring the remission of acute myeloid leukemia", Proteomics, 4, pp.3456~3463 (2004)
20. Hong JW, "Phosphorylation of serine 147 of tis21", BTG2, 2 induces Pin-1binding in cytoplasm and cell death, pp.J Biol Chem, 2005[DOI]
21. Lin WJ, "Mitogenstimulated TIS21 protein interacts with a protein-kinase-Calpha-binding protein rPICK1", Biochem J, 354, pp.635~643 (2001)
22. Sasajima H, "Antiproliferative proteins of the BTG", Tob family are degraded by the ubiquitin-proteasome system, 2002, pp.269, 3596~3604
23. Hwang SS, "mRNA destabilization by BTG1 and BTG2 maintains T cell quiescence", Science, 367, pp.1255~1260 (2020)
24. Mauxion F, "The BTG2protein is a general activator of mRNA deadenylation", EMBO J, 27, pp.1039~1048 (2008)
25. Stupfler B, "BTG2 bridges PABPC1 RNA-binding domains and CAF1deadenylase to control cell proliferation", Nat Commun, 7, pp.10811~ (2016)
26. Aslam A, "The Ccr4-NOT deadenylase subunits CNOT7 and CNOT8 have overlapping roles and modulate cell proliferation", Mol Biol Cell, 20, pp.3840~3850 (2009)
27. Venezia TA, "Molecular signatures of proliferation and quiescence in hematopoietic stem cells", PLoS Biol, 2, pp.e301~ (2004)
28. Tijchon E, "Tumor suppressors BTG1 and BTG2 regulate early mouse B-cell development", Haematologica, 101, pp.e272~e276 (2016)
29. Konrad MA, "The BTG", TOB family protein TIS21 regulates stage-specific proliferation of developing thymocytes, 2005, pp.35, 3030~3042
30. Farioli-Vecchioli S, "Btg1is required to maintain the pool of stem and progenitor cells of the Dentate Gyrus and Subventricular Zone", Front Neurosci, 6, pp.124~ (2012)
31. Zhu R, "BTG1 inhibits breast cancer cell growth through induction of cell cycle arrest and apoptosis", Oncol Rep, 30, pp.2137~2144 (2013)
32. Farioli-Vecchioli S, "Impaired terminal differentiation of hippocampal granule neurons and defective contextual memory in PC3", Tis21knockout mice, 2009, pp.4, e8339~
33. Miyata S, "PRMT1 and Btg2regulates neurite outgrowth of Neuro2a cells", Neurosci Lett, 445, pp.162~165 (2008)
34. Evangelisti C, "TIS21", BTG2, Cell Signal, pp.2009, 21[DOI]
35. Kim S, "B cell translocation gene 2(Btg2)is regulated by Stat3 signaling and inhibits adipocyte differentiation", Mol Cell Biochem, 413, pp.145~153 (2016)
36. Cho BO, "Up-regulation of the BTG2 gene in TPA-or RA-treated HL-60 cell lines", Oncol Rep, 19, pp.633~637 (2008)
37. Wei S, "Effects of BTG2 on proliferation inhibition and anti-invasion in human lung cancer cells", Tumour Biol, 33, pp.1223~1230 (2012)
38. Micheli L, "HDAC1, HDAC4, and HDAC9 bind to PC3", Tis21, J Cell Physiol, pp.2017, 232[DOI]
39. Guardavaccaro D, "Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription", Mol Cell Biol, 20, pp.1797~1815 (2000)
40. Lim IK, "Induction of growth inhibition of 293 cells by downregulation of the cyclin E and cyclin-dependent kinase 4 proteins due to overexpression of TIS21", Mol Carcinog, 23, pp.25~35 (1998)
41. Dolezal E, "The BTG2-PRMT1 module limits pre-B cell expansion by regulating the CDK4-Cyclin-D3 complex", Nat Immunol, 18, pp.911~920 (2017)
42. Chang BD, "Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent", Proc Natl Acad Sci U S A, 99, pp.389~394 (2002)
43. Wheaton K, "BTG2antagonizes Pin1 in response to mitogens and telomere disruption during replicative senescence", Aging Cell, 9, pp.747~760 (2010)
44. Kuo ML, "Arf induces p53-dependent and-independent antiproliferative genes", Cancer Res, 63, pp.1046~1053 (2003)
45. Nahta R, "B cell translocation gene 1 contributes to antisense Bcl-2-mediated apoptosis in breast cancer cells", Mol Cancer Ther, 5, pp.1593~1601 (2006)
46. Zhang Z, "Aberrant expression of the p53-inducible antiproliferative gene BTG2in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins", Cell Biochem Biophys, 61, pp.83~91 (2011)
47. Boiko AD, "A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation", Genes Dev, 20, pp.236~252 (2006)
48. Choi OR, "Shifting p53-induced senescence to cell death by TIS21(", BTG2, Cell Signal, pp.2016, 28[DOI]
49. Yuniati L, "Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress", Oncotarget, 7, pp.3128~3143 (2016)
50. Wagener N, "Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients", Br J Cancer, 108, pp.973~982 (2013)
51. Kanda M, "Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer", Dig Dis Sci, 60, pp.1256~1264 (2015)
52. Zhang SQ, "miR-511 promotes the proliferation of human hepatoma cells by targeting the 3’UTR of B cell translocation gene 1(BTG1)mRNA", Acta Pharmacol Sin, 38, pp.1161~1170 (2017)
53. He C, "MicroRNA 301A promotes intestinal inflammation and colitis-associated cancer development by inhibiting BTG1", Gastroenterology, 152, pp.1434~1448 (2017)
54. Hu X, "BTG2 overexpression increases the radiosensitivity of breast cancer cells in vitro and in vivo", Oncol Res, 20, pp.457~465 (2013)
55. Quy LN, "TIS21(", BTG2, Cell Signal, pp.2013, 25[DOI]
56. Hunter ZR, "The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis", Blood, 123, pp.1637~1646 (2014)
57. Morin RD, "Frequent mutation of histone-modifying genes in nonHodgkin lymphoma", Nature, 476, pp.298~303 (2011)
58. De Falco G, "Geneexpression analysis identifies novel RBL2", p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors, 2007, pp.110, 1301~1307
59. Pasqualucci L, "Genetics of follicular lymphoma transformation", Cell Rep, 6, pp.130~140 (2014)
60. Reddy A, "Genetic and functional drivers of diffuse large B cell lymphoma", Cell, 171, pp.481~494 (2017)
61. Yan W, "Identification of B-cell translocation gene 1-controlled gene networks in diffuse large B-cell lymphoma : a study based on bioinformatics analysis", Oncol Lett, 17, pp.2825~2835 (2019)
62. Waanders E, "The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution", PLoS Genet, 8, pp.e1002533~ (2012)
63. Scheijen B, "Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients", Haematologica, 102, pp.541~551 (2017)
64. Irving JA, "Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia", Blood, 128, pp.911~922 (2016)